XERS
¿Es Xeris Biopharma Holdings, Inc. (XERS) una buena acción según Buffett?
Xeris Biopharma Holdings, Inc. (XERS) is analysed against the documented Warren Buffett framework on this page. The Buffett-Fit score grades the stock A+ to D across five pillars (moat, earnings durability, management quality, financial health, valuation), each on a 0-100 sub-scale. The full reasoning behind every pillar is below. Educational only, not investment advice.
Five pillars at a glance. Xeris Biopharma Holdings, Inc.'s Buffett-Fit score weighs ROIC sustainability (currently 0.1%), gross-margin durability (0.8%), net-debt-to-EBITDA (-1.66x), free-cash-flow conversion (50.42x net income), and the owner-earnings yield (2.5%). Each pillar is scored 0-100 against sector-relative benchmarks.
Where XERS passes the test. A Buffett-style holding needs durable returns, conservative debt, owner-friendly management, and a price below intrinsic value. The full pillar breakdown on /buffett/xers/ shows where Xeris Biopharma Holdings, Inc. clears each bar - and where it doesn't.
What the score does NOT say. A high Buffett-Fit grade is a pattern-match against documented criteria, not a forecast. A stock graded A+ today can underperform if its underlying business deteriorates faster than the score updates. A D-graded stock can outperform if it's a value trap that recovers. The score weighs current fundamentals against a documented framework - that's all it claims to do.
How invest-like measures this
El marco Buffett-Fit en invest-like.com califica cualquier acción cotizada de A+ a D en una escala de 0 a 100 según cinco pilares ponderados: moat económico (ventaja competitiva duradera), durabilidad de los beneficios (rentabilidad consistente), calidad de la gestión (asignación de capital), salud financiera (balance conservador) y valoración (margen de seguridad).
Cada pilar se evalúa en la misma subescala de 0 a 100 según la rúbrica que Warren Buffett ha documentado en más de 50 años de cartas a accionistas de Berkshire Hathaway. La nota global es la media ponderada. Solo educativo - pattern-match contra criterios públicos documentados, no asesoramiento de inversión personalizado.
More questions about XERS
Dive deeper into XERS
Relacionado en invest-like
Análisis con el marco, con fines educativos. No es asesoramiento de inversión, ni una recomendación, ni está adaptado a tu situación personal. Haz siempre tu propia investigación.